← FDA DRUG APPROVALS

FDA NDA · NDA017914

TRIDESILON

Sponsor: BAYER PHARMS

APPLICATION
NDA017914
TYPE
NDA
ORIGINAL APPROVAL
1978-02-21
LATEST ACTION
1997-07-25
ROUTE
OTIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

TRIDESILONDiscontinued
ACETIC ACID, GLACIAL 2%, DESONIDE 0.05% · SOLUTION/DROPS · OTIC

Approval history

1997-07-25Labeling · Supplement 5AP
1991-03-04Labeling · Supplement 8AP
1988-10-17Labeling · Supplement 4AP
1980-02-29Labeling · Supplement 2AP
1978-02-21Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →